Epilepsy in neuro-oncology: a review
Main Article Content
Keywords
Brain tumours, systemic neoplasia, epilepsy, anticonvulsants, treatment guidelines
Abstract
Epilepsy associated with neoplastic diseases in any site is a poorly understood manifestation that has important clinical and social implications. This article comprises a review based on a practical approach to three main categories of the population affected: 1) seizure or epilepsy in patients with structural active neoplastic brain lesions (primary or metastatic): strictly and commonly identified as “brain-tumour associated epilepsy (TAE)”; 2) seizure or epilepsy in patients without structural active neoplastic brain lesions: peri/post-operative period for any other CNS oncologic surgery; vascular, paraneoplastic and infectious complications in systemic cancers; and 3) seizure or epilepsy in various other conditions of any cancer: history of a previous CNS tumour (but not expression of active neoplastic CNS disease) or toxicity of its treatments, mainly radiotherapy; metabolic and treatmens complications in systemic cancers, etc. These statements may be shared and spread among neuro-oncologists, general practitioners, medical doctors in emergency rooms and any other specialist involved in the management of such patients.
Article Sidebar
Article Details
How to Cite
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.